Table 3

EpCAM expression in genitourinary tract cancers

Tumour type (no. of samples)No EpCAM overexpression*EpCAM overexpression*
No expression (TIS 0)Weak expression (TIS 1–4)Moderate expression (TIS 6, 8)Intense expression (TIS 9, 12)
Ovarian cancer (326)27863191003113642
 Serous, endometrioid and other histologies (268)2184316873211744
 Mucinous histology (58)610203513221933
Renal cancer (122)6150141215123226
 Clear cell histology (48)38794951012
 Non-clear-cell histology (74)2331101410143141
Urothelial cancer (91)51561517212344
Endometrial cancer (70)464616234665
Prostate cancer (108)11111035326157
SCC of the cervix, vagina and vulva (92)5459141513141112
  • EpCAM expression was determined by immunohistochemistry.

  • * EpCAM overexpression defined by Gastl et al3.

  • EpCAM, epithelial cell adhesion molecule; SCC, squamous cell cancer; TIS, total immunostaining score.